Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peripheral blood flow in chronic ergotism

H Leinonen

    Acta Medica Scandinavica
    |January 1, 1980
    PubMed
    Summary

    Chronic ergotamine tartrate overdose did not affect muscle blood flow (MBF) in most patients. However, high doses significantly reduced MBF before circulatory symptoms appeared, indicating potential early vascular damage.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Is unfractionated heparin still needed?].

    Duodecim; laaketieteellinen aikakauskirja·2002
    Same author

    [What was behind the brain infarctions?].

    Duodecim; laaketieteellinen aikakauskirja·2002
    Same author

    [A newly found cause for sudden cardiac death].

    Duodecim; laaketieteellinen aikakauskirja·2002
    Same author

    [Coronary circulation].

    Duodecim; laaketieteellinen aikakauskirja·2001
    Same author

    [The heart's function as a pump].

    Duodecim; laaketieteellinen aikakauskirja·2001
    Same author

    Purification of metal finishing waste waters with zeolites and activated carbons.

    Waste management & research : the journal of the International Solid Wastes and Public Cleansing Association, ISWA·2001

    Area of Science:

    • Pharmacology
    • Vascular Physiology
    • Clinical Medicine

    Background:

    • Ergotamine tartrate is used for migraines.
    • Chronic overdose can lead to ergotism, a condition involving vascular issues.
    • Early detection of vascular compromise is crucial.

    Purpose of the Study:

    • To investigate the effect of chronic ergotamine tartrate overdose on muscle blood flow (MBF).
    • To determine if high-dose ergotamine tartrate impacts MBF before clinical symptoms manifest.

    Main Methods:

    • Muscle blood flow (MBF) was measured using the 133xenon clearance technique.
    • 11 patients on chronic ergotamine tartrate overdose were compared to 12 healthy controls.
    • MBF in patients exceeding 0.25 mg/kg/week of ergotamine was specifically analyzed.

    Main Results:

    • No significant difference in MBF was observed between the overall ergotamine tartrate group and controls.
    • Patients taking ergotamine tartrate doses > 0.25 mg/kg/week showed a significant reduction in MBF (p < 0.01).
    • This reduction in MBF was detectable prior to any clinical signs or symptoms of circulatory insufficiency.

    Conclusions:

    • Chronic ergotamine tartrate overdose does not universally impair muscle blood flow.
    • High-dose ergotamine tartrate (> 0.25 mg/kg/week) significantly reduces muscle blood flow.
    • Reduced MBF may serve as an early, subclinical indicator of ergotamine-induced vascular toxicity.

    Related Experiment Videos